• Image of DARZALEX FASPRO medication Image of DARZALEX FASPRO medication
    • DARZALEX FASPRO

    • QTY 30
    • 1800-30000
    • VIAL
    • Near  77381

DARATUMUMAB; HYALURONIDASE (DAR a TOOM ue mab; hye al ur ON i dase) treats multiple myeloma, a type of bone marrow cancer. Daratumumab works by blocking a protein that causes cancer cells to grow and multiply. This helps to slow or stop the spread of cancer cells. Hyaluronidase helps your body absorb this medication. This helps it work better in your body. This medication may also be used treat amyloidosis, a condition that causes the buildup of a protein (amyloid) in your body. It works by reducing the buildup of this protein, which decreases symptoms. It is a combination medication that contains a monoclonal antibody.


DARZALEX FASPRO Information

En Español En Español

DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment. Drug information is sourced from GSDD (Gold Standard Drug Database ) provided by Elsevier.